May 7, 2009
Q1 A Bitter Pill For Psychemedics
By Matthew L. Brown
Psychemedics Corp. of Acton said it ended the first quarter with a $39,000 profit on $4.1 million in revenue, both significant declines from a year ago.
For the first quarter of last year, the drug testing company reported a profit of $890,000 on $5.7 million in revenue.
Despite the declines, the company declared a $0.17 per share dividend and said that it knows how to manage the company "in difficult environments."
The company ended the quarter with $5.5 million in cash and no long-term debt on its balance sheet. That gives the company "a solid economic platform to weather storms," and the ability to take advantage of growth opportunities, the company said.
WBJ Web Partners
Most Recent
Most Recent
0 Comments